BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$2.76B |
| 2 |
Analog Devices
ADI
|
+$2.38B |
| 3 |
Amazon
AMZN
|
+$2.01B |
| 4 |
Tesla
TSLA
|
+$1.68B |
| 5 |
Snowflake
SNOW
|
+$1.58B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$3.21B |
| 2 |
MXIM
Maxim Integrated Products
MXIM
|
+$2.54B |
| 3 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$1.28B |
| 4 |
Alibaba
BABA
|
+$1.25B |
| 5 |
WORK
Slack Technologies, Inc.
WORK
|
+$1.15B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.12% |
| 2 | Healthcare | 13.68% |
| 3 | Financials | 13.15% |
| 4 | Consumer Discretionary | 11.13% |
| 5 | Communication Services | 8.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3401
BlackBerry
BB
$5.27B
| $16.2M | ﹤0.01% |
1,667,278
+107,596
| +7% | +$1.13M |
|
3402
Atlanta Braves Holdings Series A
BATRA
$3.63B
| $16.2M | ﹤0.01% |
600,879
-36,411
| -6% | -$972K |
|
|
ADVM
3403
DELISTED
Adverum Biotechnologies
ADVM
| $16.1M | ﹤0.01% |
743,507
-54,805
| -7% | -$1.4M |
|
3404
Dianthus Therapeutics
DNTH
$6.13B
| $16.1M | ﹤0.01% |
138,478
+5,534
| +4% | +$645K |
|
3405
Lifetime Brands
LCUT
$219M
| $16.1M | ﹤0.01% |
884,186
+3,010
| +0.3% | +$50.3K |
|
|
XIFR
3406
XPLR Infrastructure LP
XIFR
$1.08B
| $16M | ﹤0.01% |
212,672
+1,170
| +0.6% | +$91.2K |
|
|
DS
3407
DELISTED
Drive Shack Inc.
DS
| $16M | ﹤0.01% |
5,681,685
+28,435
| +0.5% | +$76.5K |
|
3408
Intercorp Financial Services
IFS
$6.06B
| $15.9M | ﹤0.01% |
713,744
+23,876
| +3% | +$521K |
|
3409
AquaBounty Technologies
AQB
$7.72M
| $15.9M | ﹤0.01% |
195,547
+7,178
| +4% | +$672K |
|
3410
Cardiff Oncology
CRDF
$77.1M
| $15.9M | ﹤0.01% |
2,387,748
+27,765
| +1% | +$174K |
|
3411
Pampa Energía
PAM
$4.26B
| $15.9M | ﹤0.01% |
909,942
-10,127
| -1% | -$167K |
|
3412
Blue Ridge Bankshares
BRBS
$339M
| $15.9M | ﹤0.01% |
903,686
+7,260
| +0.8% | +$127K |
|
3413
XBiotech
XBIT
$75M
| $15.8M | ﹤0.01% |
1,223,654
+22,057
| +2% | +$351K |
|
3414
Hillman Solutions
HLMN
$1.73B
| $15.8M | ﹤0.01% |
1,326,072
+1,325,462
| +217,289% | +$16.2M |
|
|
LTRPA
3415
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
| $15.7M | ﹤0.01% |
5,096,524
+25,275
| +0.5% | +$94K |
|
|
ZY
3416
DELISTED
Zymergen Inc. Common Stock
ZY
| $15.7M | ﹤0.01% |
1,193,477
-7,082
| -0.6% | -$150K |
|
|
MLNK
3417
DELISTED
MeridianLink
MLNK
| $15.7M | ﹤0.01% |
+701,134
| New | +$17.3M |
|
3418
Instil Bio
TIL
$49.3M
| $15.7M | ﹤0.01% |
43,799
+2,032
| +5% | +$759K |
|
3419
ENI
E
$79.6B
| $15.6M | ﹤0.01% |
584,608
+6,583
| +1% | +$160K |
|
|
ONIT
3420
Onity Group
ONIT
$321M
| $15.6M | ﹤0.01% |
555,885
-4,708
| -0.8% | -$130K |
|
|
NIU
3421
Niu Technologies
NIU
$162M
| $15.6M | ﹤0.01% |
674,517
+63,234
| +10% | +$1.68M |
|
3422
Foghorn Therapeutics
FHTX
$394M
| $15.6M | ﹤0.01% |
1,119,685
+25,825
| +2% | +$286K |
|
|
ENLC
3423
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
| $15.6M | ﹤0.01% |
2,284,158
-30,932
| -1% | -$181K |
|
|
LENZ
3424
LENZ Therapeutics
LENZ
$145M
| $15.6M | ﹤0.01% |
135,702
+120,905
| +817% | +$17.9M |
|
|
IMDX
3425
Insight Molecular Diagnostics
IMDX
$147M
| $15.6M | ﹤0.01% |
218,437
-18,049
| -8% | -$1.66M |
|
Similar funds
BlackRock's Q3 2021 Portfolio in Review
As of Q3 2021, BlackRock held 5,803 positions worth $3.57T, down 0.58% from $3.59T the previous quarter. Its ten largest holdings account for 19% of the portfolio.
BlackRock's Q3 2021 filing shows 283 new, 2,199 increased, 2,669 reduced and 164 closed positions. Its largest new stake was GXO Logistics: 8,566,775 shares worth $672M. The largest sale was Alexion Pharmaceuticals, an estimated $3.21B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q3 2021 buy was GXO Logistics: 8,566,775 shares worth $672M.
- BlackRock added most to Moderna in Q3 2021, an estimated $2.76B increase.
- BlackRock's biggest Q3 2021 reduction was Vanguard Short-Term Corporate Bond ETF, cutting an estimated $1.28B.
- BlackRock fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $3.21B.
- BlackRock's ten largest holdings make up 19% of its $3.57T portfolio in Q3 2021.
- BlackRock opened 283 new positions and closed 164 in Q3 2021.
- BlackRock's portfolio value fell 0.58% quarter-over-quarter to $3.57T.
Based on BlackRock's 13F filing for Q3 2021, filed 9 Nov 2021.